Accelerating Progress in Human Health and Scientific Research

At Parse Biosciences, we are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Single cell RNA sequencing has already enabled breakthroughs in developmental biology, stem cell therapy, immunotherapy, and cancer treatments. Our foundational Evercode™ combinatorial barcoding technology is driving the next generation of discoveries.

Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research.

The People of Parse

The people of Parse are curious, collaborative, and driven by purpose.

Upcoming Events

Festival Of Genomics

Jan 25   -   Jan 26

The 8th annual Festival of Genomics will be the largest genomics event in the UK and in Europe and will cover the entire genomics workflow end-to-end, as well as how genomics data is integrated with forms of biodata to help you make meaningful research and clinical decisions. Parse Biosciences staff will share information about our single cell platform on during lunch on Day One.

More Information

Advances in Genome Biology and Technology (AGBT)

Feb 6   -   Feb 9

Parse Biosciences is proud to be a Bronze Sponsor at AGBT’s flagship event for bringing together global leaders, researchers, and innovators. If you are attending, please visit us in suite 215.

More Information

NextGen Omics US

Mar 30   -   Mar 31

The NextGen Omics US: In-Person event is an exclusive collaborative environment, welcoming over 300 attendees from international Pharma, Biotech & Academic institutions. Parse Biosciences team members will discuss our Evercode single cell RNA sequencing platform in a Day One presentation.

More Information

Leadership